Bilaketaren emaitzak - Timo D. Müller

Findu emaitzak
  1. 1
    The molecular pharmacology of glucagon agonists in diabetes and obesity

    The molecular pharmacology of glucagon agonists in diabetes and obesity nork Aaron Novikoff, Timo D. Müller

    Argitaratua 2023
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments

    (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments nork Günter Müller, Timo D. Müller

    Argitaratua 2023
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Antagonizing GIPR adds fire to the GLP-1R flame

    Antagonizing GIPR adds fire to the GLP-1R flame nork Aaron Novikoff, Timo D. Müller

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Incretin hormones and type 2 diabetes

    Incretin hormones and type 2 diabetes nork Michael A. Nauck, Timo D. Müller

    Argitaratua 2023
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Therapeutic Potential of Targeting the Ghrelin Pathway

    Therapeutic Potential of Targeting the Ghrelin Pathway nork Gustav Colldén, Matthias H. Tschöp, Timo D. Müller

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Ghrelin regulation of glucose metabolism

    Ghrelin regulation of glucose metabolism nork Anne-Laure Poher, Matthias H. Tschöp, Timo D. Müller

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Gut hormone polyagonists for the treatment of type 2 diabetes

    Gut hormone polyagonists for the treatment of type 2 diabetes nork Sara J. Brandt, A. Götz, Matthias H. Tschöp, Timo D. Müller

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes nork Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, Timo D. Müller

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Anti-obesity drug discovery: advances and challenges

    Anti-obesity drug discovery: advances and challenges nork Timo D. Müller, Matthias Blüher, Matthias H. Tschöp, Richard D. DiMarchi

    Argitaratua 2021
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia

    Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia nork Timo D. Müller, Diego Pérez–Tilve, Jenny Tong, Paul T. Pfluger, Matthias H. Tschöp

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Anti-Obesity Therapy: from Rainbow Pills to Polyagonists

    Anti-Obesity Therapy: from Rainbow Pills to Polyagonists nork Timo D. Müller, Christoffer Clemmensen, Brian Finan, Richard D. DiMarchi, M. Tschöp

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Glucagon Regulation of Energy Expenditure

    Glucagon Regulation of Energy Expenditure nork Maximilian Kleinert, Stephan Sachs, Kirk M. Habegger, Susanna M. Hofmann, Timo D. Müller

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology

    Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology nork Sara J. Brandt, Timo D. Müller, Richard D. DiMarchi, M. Tschöp, Kerstin Stemmer

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Glucagon's Metabolic Action in Health and Disease

    Glucagon's Metabolic Action in Health and Disease nork Anja Zeigerer, Revathi Sekar, Maximilian Kleinert, Shelly Nason, Kirk M. Habegger, Timo D. Müller

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Gut-Brain Cross-Talk in Metabolic Control

    Gut-Brain Cross-Talk in Metabolic Control nork Christoffer Clemmensen, Timo D. Müller, Stephen C. Woods, Hans-Rudolf Berthoud, Randy J. Seeley, Matthias H. Tschöp

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  16. 16
    GLP-1/glucagon receptor co-agonism for treatment of obesity

    GLP-1/glucagon receptor co-agonism for treatment of obesity nork Miguel A. Sánchez-Garrido, Sara J. Brandt, Christoffer Clemmensen, Timo D. Müller, Richard D. DiMarchi, Matthias H. Tschöp

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  17. 17
    GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications

    GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications nork Jonathan E. Campbell, Timo D. Müller, Brian Finan, Richard D. DiMarchi, Matthias H. Tschöp, David A. D’Alessio

    Argitaratua 2023
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Unimolecular Polypharmacy for Treatment of Diabetes and Obesity

    Unimolecular Polypharmacy for Treatment of Diabetes and Obesity nork Matthias H. Tschöp, Brian Finan, Christoffer Clemmensen, Vasily M. Gelfanov, Diego Pérez–Tilve, Timo D. Müller, Richard D. DiMarchi

    Argitaratua 2016
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

    Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes nork Qiming Tan, Seun Akindehin, Camila E. Orsso, Richelle C. Waldner, Richard D. DiMarchi, Timo D. Müller, Andrea M. Haqq

    Argitaratua 2022
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  20. 20
    'Fat mass and obesity associated' gene (FTO): No significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents

    'Fat mass and obesity associated' gene (FTO): No significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German ob... nork Timo D. Müller, Anke Hinney, André Scherag, Thuy Trang Nguyen, Felix Schreiner, H. Schäfer, Johannes Hebebrand, Christian L. Roth, Thomas Reinehr

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: